Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients

• Váldodahkkit: Eleni Manou (Dahkki), Elias Thodis (Dahkki), Georgios Arsos (Dahkki), Ploumis Pasadakis (Dahkki), Stylianos Panagoutsos (Dahkki), Dorothea Papadopoulou (Dahkki), Aikaterini Papagianni (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Karger Publishers, 2020-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Fibroblast growth factor 23 (FGF-23) and α-Klotho protein appear to have an important role in the pathogenesis of CKD-mineral and bone disorders. The aim of this study was to investigate the association of FGF-23 and α-Klotho levels with adverse clinical outcomes in patients with non-dia...